Finance

Lists
WST:NYSE
West Pharmaceutical Services Inc
$ 413.38
+0.13%
(+0.55) 1D
11-р сарын 10, 15:01:01 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WST...
Open
$ 410.88
High
$ 415.41
Low
$ 408.80
Mkt. cap
28.80 тэрбум
Avg. vol.
683.20 мян
Volume
186.58 мян
Dividend
0.25%
Quarterly dividend
$ 0.26
Ex-dividend date
2026 оны 7-р сарын 29
P/E ratio
46.36
52-wk high
$ 438.27
52-wk low
$ 223.83
EPS
$ 8.92
Beta
1.13
Shares outstanding
69.66 сая
No. of employees
11 мян
Open
$ 410.88
High
$ 415.41
Low
$ 408.80
Mkt. cap
28.80 тэрбум
Avg. vol.
683.20 мян
Volume
186.58 мян
Dividend
0.25%
Quarterly dividend
$ 0.26
Ex-dividend date
2026 оны 7-р сарын 29
P/E ratio
46.36
52-wk high
$ 438.27
52-wk low
$ 223.83
EPS
$ 8.92
Beta
1.13
Shares outstanding
69.66 сая
No. of employees
11 мян
News stories
From web sources and news partners
Profile
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. Wikipedia
About West Pharmaceutical Services Inc
CEOEric M. Green
Employees10.8 мян
Founded1923
HeadquartersWest Whiteland Township, Пеннсилвани, Америкийн Нэгдсэн Улс
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to WST in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for WST in the last 3 months.
Highest
Current $ 413.38
$ 500.00 (+20.95%)
Average
$ 478.17 (+15.67%)
Lowest
$ 400.00 (-3.24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brendan Smith
TD Cowen
Buy
Maintained
$ 500.00
+21%
10/29/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
$ 480.00
+16.1%
10/30/2026
Unknown Analyst
UBS
Buy
Maintained
$ 495.00
+19.7%
10/30/2026
Doug Schenkel
UBS
Buy
Maintained
$ 495.00
+19.7%
10/30/2026
Joanne Wuensch
Citi
Buy
Reiterated
$ 494.00
+19.5%
10/30/2026
Luke Sergott
Barclays
Buy
Maintained
$ 500.00
+21%
10/30/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Upgraded
$ 400.00
-3.2%
09/22/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
$ 410.00
-0.8%
07/24/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/23/2026
Curtis Moiles
Exane BNP Paribas
Buy
Initiated
$ 447.00
+8.1%
07/13/2026
Paul Knight
KeyBanc
Buy
Maintained
$ 390.00
-5.7%
07/02/2026
Michael Polark
Wolfe Research
Buy
Reiterated
$ 375.00
-9.3%
06/01/2026
Patrick B Donnelly
Citi
Buy
Maintained
$ 400.00
-3.2%
04/24/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
-
-
04/23/2026
Dan Leonard
UBS
Buy
Maintained
$ 340.00
-17.8%
02/13/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
$ 315.00
-23.8%
02/13/2026
David Windley
Jefferies
Buy
Maintained
$ 295.00
-28.6%
02/10/2026
Nico Chen
DBS
Buy
Maintained
$ 320.00
-22.6%
01/28/2026
Last report
2026 оны 10-р сарын 29
Fiscal period
Q3 2026
$ 2.66 / $ 2.20
+21.12%beat
Revenue / Est. (USD)
874.50 сая / 826.55 сая
+5.80%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
805.00 сая
844.90 сая
872.30 сая
874.50 сая
Cost of goods sold
501.10 сая
548.50 сая
543.10 сая
527.10 сая
Cost of revenue
501.10 сая
548.50 сая
543.10 сая
527.10 сая
Research and development expenses
21.80 сая
15.80 сая
19.70 сая
18.30 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.50 сая
99.50 сая
112.00 сая
108.80 сая
Operating expense
129.70 сая
113.10 сая
133.20 сая
125.50 сая
Total operating expenses
630.80 сая
661.60 сая
676.30 сая
652.60 сая
Operating income
174.20 сая
183.30 сая
196.00 сая
221.90 сая
Other non operating income
600.00 мян
-200.00 мян
-200.00 мян
-200.00 мян
EBT including unusual items
165.40 сая
183.50 сая
186.20 сая
272.00 сая
EBT excluding unusual items
181.20 сая
188.60 сая
201.20 сая
225.60 сая
Income tax expense
33.30 сая
44.70 сая
32.20 сая
58.00 сая
Effective tax rate
20.13%
24.36%
17.29%
21.32%
Other operating expenses
400.00 мян
-2.20 сая
1.50 сая
-1.60 сая
Net income
132.10 сая
138.80 сая
154.00 сая
214.00 сая
Net profit margin
16.41%
16.43%
17.65%
24.47%
Earnings per share
2.04
2.13
2.37
2.66
Interest and investment income
5.30 сая
5.10 сая
3.80 сая
4.30 сая
Interest expense
-
-1.90 сая
-2.60 сая
-3.80 сая
Net interest expenses
5.30 сая
3.20 сая
1.20 сая
500.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
221.20 сая
228.50 сая
242.20 сая
267.80 сая
Gain or loss from assets sale
-
-
-
-55.70 сая
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс